Recent advances in the management of lung cancer
Gavin S Jones and David R Baldwin
DOI: https://doi.org/10.7861/clinmedicine.18-2-s41
Clin Med April 2018 Gavin S Jones
ADivision of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
Roles: clinical research fellow
David R Baldwin
BDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
CDepartment of Respiratory Medicine, Nottingham University hospitals, Nottingham, UK
Roles: honorary professor of medicine, consultant respiratory physician
Article Information
vol. 18 no. Suppl 2 s41-s46
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online April 26, 2018.
Copyright & Usage:
© Royal College of Physicians 2018. All rights reserved.
Author Information
- Gavin S Jones, clinical research fellowA and
- David R Baldwin, honorary professor of medicineB, consultant respiratory physicianC⇑
- ADivision of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
- BDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
- CDepartment of Respiratory Medicine, Nottingham University hospitals, Nottingham, UK
- Address for correspondence: Prof David Baldwin, Department of Respiratory Medicine, David Evans Building, Nottingham University Hospitals, City campus, Nottingham NG5 1PB, UK. Email: David.Baldwin{at}nottingham.ac.uk
Article usage
Article Tools
Recent advances in the management of lung cancer
Gavin S Jones, David R Baldwin
Clinical Medicine Apr 2018, 18 (Suppl 2) s41-s46; DOI: 10.7861/clinmedicine.18-2-s41
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
- Sequential administration of pemetrexed and cisplatin reprograms tumor immune microenvironment and potentiates PD-1/PD-L1 treatment in a lung cancer model
- Role of extracellular vesicles in chronic lung disease
- Defining timeliness in care for patients with lung cancer: protocol for a scoping review